Immunitybio Inc (IBRX)

Operating Income Growth

11.76%

TTM · Period ending:

IBRX logo

IBRX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported11.76%
IBRX TTM Operating Income YoY % (51.06% → 11.76%)
High-resolution chart · PNG

IBRX operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Immunitybio Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
11.7624%
16.5997%
25.6129%
27.6055%
20.7433%
9.3825%
4.9877%
0.2517%
3.1457%
5.5592%
-3.3179%
-4.4574%
-11.4005%
-7.717%
-6.1575%
-22.6257%
-24.0844%
-45.3294%
-79.1291%
-61.9194%
-117.2441%
-161.2225%
-160.5245%
-157.9285%
-63.8883%
-3.4098%
26.5047%
34.8472%
27.1313%
12.8136%
0.0021%
-7.8887%
0.5841%
13.6776%
20.6039%
44.8337%
43.5749%
51.064%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.